Literature DB >> 4175472

Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease.

J M McKenzie, E P McCullagh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4175472     DOI: 10.1210/jcem-28-8-1177

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  9 in total

1.  Heterogeneity of failure of visual acuity in Graves' disease.

Authors:  Y Sachdev; J C Chatterji; R C Sharma
Journal:  Postgrad Med J       Date:  1979       Impact factor: 2.401

2.  The pathogenesis and treatment of Graves' ophthalmopathy.

Authors:  I R Jones
Journal:  Postgrad Med J       Date:  1987-09       Impact factor: 2.401

Review 3.  Endocrine exophthalmos.

Authors:  C W Havard
Journal:  Br Med J       Date:  1972-02-05

Review 4.  Aetiology of hyperthyroidism. II.

Authors:  R Hoffenberg
Journal:  Br Med J       Date:  1974-08-24

5.  [Endocrine ophthalmopathy in Graves disease during antithyroid drug therapy (author's transl)].

Authors:  H Wuttke; D Schlieter; F Krück
Journal:  Klin Wochenschr       Date:  1979-01-15

6.  A specific IgG in Graves' ophthalmopathy and its relation to retro-orbital and thyroid autoimmunity.

Authors:  P Kendall-Taylor; S Atkinson; M Holcombe
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-21

7.  [The problems surrounding subtotal struma resection in hyperthyroidism with endocrinous Ophthalmopathy (author's transl)].

Authors:  J Schumann; V Grabs
Journal:  Langenbecks Arch Chir       Date:  1975-09-10

8.  The binding of ( 3 H)thyrotropin and an 3 H-labeled exophthalmogenic factor by plasma membranes of retro-orbital tissue.

Authors:  R J Winand; L D Kohn
Journal:  Proc Natl Acad Sci U S A       Date:  1972-07       Impact factor: 11.205

Review 9.  Graves' ophthalmopathy.

Authors:  J R Wall; J Henderson; C R Strakosch; D M Joyner
Journal:  Can Med Assoc J       Date:  1981-04-01       Impact factor: 8.262

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.